ACADIA Pharmaceuticals (ACAD) News Today $21.60 -0.69 (-3.10%) Closing price 04:00 PM EasternExtended Trading$21.05 -0.55 (-2.54%) As of 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACAD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Zacks Research Has Pessimistic Outlook of ACAD Q2 EarningsACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) - Investment analysts at Zacks Research cut their Q2 2025 EPS estimates for ACADIA Pharmaceuticals in a research report issued on Wednesday, May 28th. Zacks Research analyst A. Chakraborty now forecasts that the biopharmaceutical company wilMay 30 at 8:07 AM | marketbeat.comAcadia Pharmaceuticals to Participate in the Goldman Sachs 46th Annual Global Healthcare ConferenceMay 29 at 4:05 PM | businesswire.comPhocas Financial Corp. Increases Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Phocas Financial Corp. lifted its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 79.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 107,811 shares of the biopharmaceutical company's stock after buying an aMay 29 at 5:45 AM | marketbeat.comJefferies Financial Group Inc. Invests $2.11 Million in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Jefferies Financial Group Inc. purchased a new stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 114,766 shares of the biophMay 29 at 5:28 AM | marketbeat.comWoodline Partners LP Buys Shares of 26,765 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Woodline Partners LP bought a new stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 26,765 shares of the biopharmaceutical company's stMay 28 at 4:30 AM | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Sold by Squarepoint Ops LLCSquarepoint Ops LLC reduced its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 67.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 185,313 shares of the biopharmaMay 28 at 4:10 AM | marketbeat.comAcadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President, Rare Disease FranchiseMay 27 at 4:05 PM | businesswire.comRett Syndrome Market Sees Momentum with Novel Gene and Protein-Targeted Therapies | DelveInsightMay 26, 2025 | finance.yahoo.com55,133 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Bought by CTC Alternative Strategies Ltd.CTC Alternative Strategies Ltd. acquired a new position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 55,133 shares of the biopharmaceutical companMay 26, 2025 | marketbeat.comNeo Ivy Capital Management Raises Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Neo Ivy Capital Management boosted its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 1,551.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5May 26, 2025 | marketbeat.comVoloridge Investment Management LLC Decreases Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Voloridge Investment Management LLC lessened its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 44.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 725,508 shares of the biopharmaceutical cMay 26, 2025 | marketbeat.com55,566 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Purchased by Alpine Global Management LLCAlpine Global Management LLC acquired a new position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 55,566 shares of the biopharmaceutical company's stock, valued at approMay 25, 2025 | marketbeat.comJT Stratford LLC Invests $278,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)JT Stratford LLC purchased a new stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 15,170 shares of the biopharmaceutical company's stock, valueMay 25, 2025 | marketbeat.comNuveen Asset Management LLC Reduces Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Nuveen Asset Management LLC trimmed its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 1.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,347,093 shares of the biopharmaceutical company's stock after sMay 25, 2025 | marketbeat.comBank of America Corp DE Raises Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Bank of America Corp DE boosted its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 41.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 680,853 shares of the biopharmaceutiMay 25, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stock Holdings Lifted by Two Sigma Investments LPTwo Sigma Investments LP grew its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 12.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,243,442 shares of the biopharmaceutical compaMay 24, 2025 | marketbeat.comDeutsche Bank Upgrades ACADIA Pharmaceuticals (BMV:ACAD)May 23, 2025 | nasdaq.comACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Up 3.5% After Analyst UpgradeACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Up 3.5% Following Analyst UpgradeMay 23, 2025 | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Raised to $35.00 at Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft boosted their price target on ACADIA Pharmaceuticals to $35.00 and gave the company a "buy" rating in a report on Wednesday.May 23, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for ACAD FY2027 Earnings?ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) - HC Wainwright lifted their FY2027 earnings per share estimates for ACADIA Pharmaceuticals in a note issued to investors on Monday, May 19th. HC Wainwright analyst A. Fein now anticipates that the biopharmaceutical company will post earningMay 23, 2025 | marketbeat.comTwo Sigma Advisers LP Buys 778,900 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Two Sigma Advisers LP grew its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 160.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,263,200 shares of the biopharmaceutical company's stock after purchasing aMay 23, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Sold by Millennium Management LLCMillennium Management LLC lessened its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 45.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,118,361 shares of the biopharmaceuticaMay 23, 2025 | marketbeat.comMorgan Stanley Forecasts Strong Price Appreciation for ACADIA Pharmaceuticals (NASDAQ:ACAD) StockMay 23, 2025 | americanbankingnews.comACADIA Pharmaceuticals (NASDAQ:ACAD) Upgraded at Wall Street ZenMay 23, 2025 | americanbankingnews.comRafferty Asset Management LLC Trims Stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Rafferty Asset Management LLC reduced its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 47.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 150,234 shares of the biopharmaceutical compMay 22, 2025 | marketbeat.comDeutsche Bank Upgrades ACADIA Pharmaceuticals (ACAD)May 22, 2025 | msn.comACADIA Pharmaceuticals (NASDAQ:ACAD) Given New $35.00 Price Target at Deutsche Bank AktiengesellschaftMay 22, 2025 | americanbankingnews.comACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Up 3.5% Following Analyst UpgradeMay 22, 2025 | americanbankingnews.comACADIA Pharmaceuticals (NASDAQ:ACAD) Trading Down 4.4% on Insider SellingMay 22, 2025 | americanbankingnews.comAcadia Pharmaceuticals secures new lease, wins patent caseMay 21, 2025 | investing.comNeedham & Company LLC Forecasts Strong Price Appreciation for ACADIA Pharmaceuticals (NASDAQ:ACAD) StockNeedham & Company LLC raised their price objective on ACADIA Pharmaceuticals from $27.00 to $30.00 and gave the stock a "buy" rating in a research note on Monday.May 21, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock PriceHC Wainwright raised their price target on ACADIA Pharmaceuticals from $27.00 to $32.00 and gave the company a "buy" rating in a report on Monday.May 21, 2025 | marketbeat.comVirtus Investment Advisers Inc. Invests $722,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Virtus Investment Advisers Inc. acquired a new position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 39,370 shares of the biopharmaceutical company's stock, vaMay 21, 2025 | marketbeat.comMizuho Raises ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $23.00May 21, 2025 | americanbankingnews.comRobert W. Baird Increases ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $31.00May 21, 2025 | americanbankingnews.comACADIA Pharmaceuticals (NASDAQ:ACAD) Earns Outperform Rating from Royal Bank of CanadaMay 21, 2025 | americanbankingnews.comACADIA Pharmaceuticals (ACAD) Gets a Hold from Mizuho SecuritiesMay 20, 2025 | theglobeandmail.comACADIA Pharmaceuticals Stock Sees RS Rating Jump To 93May 20, 2025 | msn.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Position Increased by Stonepine Capital Management LLCStonepine Capital Management LLC grew its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 11.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 220,000 shares of the biopharmaceutical compaMay 20, 2025 | marketbeat.comInsider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) EVP Sells 2,000 Shares of StockMay 20, 2025 | insidertrades.comACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Expected to Rise, BMO Capital Markets Analyst SaysMay 20, 2025 | americanbankingnews.comHC Wainwright Boosts ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $32.00May 20, 2025 | americanbankingnews.comPoint72 Hong Kong Ltd Purchases Shares of 24,054 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Point72 Hong Kong Ltd purchased a new stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 24,054 shares of the biopharmaceutical coMay 19, 2025 | marketbeat.comMan Group plc Has $22.41 Million Stock Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Man Group plc lowered its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 4.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,221,022 shares of the biopharmaceutical cMay 19, 2025 | marketbeat.comLazard Asset Management LLC Has $2.77 Million Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Lazard Asset Management LLC grew its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 55.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 150,928 shares of the biopharmaceutical company's stock aftMay 19, 2025 | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 12-Month High - Time to Buy?ACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 1-Year High - What's Next?May 19, 2025 | marketbeat.comGotham Asset Management LLC Acquires 34,240 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Gotham Asset Management LLC lifted its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 95.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 69,966 shares of theMay 19, 2025 | marketbeat.comAmeriprise Financial Inc. Purchases 120,996 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Ameriprise Financial Inc. boosted its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 15.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 884,870 shares of the biopharmaceutical company's stMay 19, 2025 | marketbeat.comSphera Funds Management LTD. Buys 36,000 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Sphera Funds Management LTD. increased its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 14.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 288,539 shares of the biopharmaceutical company's stockMay 18, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Sold by RTW Investments LPRTW Investments LP cut its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 36.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 8,705,501 shares of the biopharmaceutical company's stock after selling 5,002,005 shares duringMay 18, 2025 | marketbeat.com Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Email Address ACAD Media Mentions By Week ACAD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACAD News Sentiment▼0.920.87▲Average Medical News Sentiment ACAD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACAD Articles This Week▼219▲ACAD Articles Average Week Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Intra-Cellular Therapies News Genmab A/S News Dr. Reddy's Laboratories News Moderna News Ascendis Pharma A/S News Viatris News Qiagen News Roivant Sciences News Revolution Medicines News Blueprint Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACAD) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACAD Stock Free ACAD Stock Alerts